As shown in Table 1, there were significant differences between the INF‐a/b and INF‐c groups in age, sex distribution, tumor location, type of gastrectomy, pathological stage, and administration rate of postoperative adjuvant chemotherapy. This evidence concerns the gene CBLIF and neoplasm.